Upregulation of SATB1 is associated with the development and progression of glioma

Journal of Translational Medicine

Volumn 10, Issue 1, 2012, Pages

  Chu, Sheng Hua ^a   Ma, Yan Bin ^a   Feng, Dong Fu ^a   Zhang, Hong ^a   Zhu, Zhi An ^a   Li, Zhi Qiang ^b   Jiang, Pu Cha ^b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; KI 67 ANTIGEN; MEMBRANE PROTEIN; MESSENGER RNA; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; NUCLEAR MATRIX PROTEIN; PROTEIN BCL 2; PROTEIN SLC22A18; SCATTER FACTOR RECEPTOR; SEMUSTINE; SHORT HAIRPIN RNA; SPECIAL AT RICH SEQUENCE BINDING PROTEIN 1; TEMOZOLOMIDE; TENIPOSIDE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER INVASION; CANCER PROGNOSIS; CANCER SURGERY; CANCER SURVIVAL; CANCER TISSUE; CARCINOGENESIS; CELL ADHESION; CELL GROWTH; CELL STRAIN U251; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA METHYLATION; FEMALE; GENE EXPRESSION; GENETIC TRANSFECTION; GLIOMA; GLIOMA CELL; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; METASTASIS; MOUSE; NONHUMAN; OVERALL SURVIVAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA SEQUENCE; TUMOR VASCULARIZATION; TUMOR XENOGRAFT; UPREGULATION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; BRAIN NEOPLASMS; CELL ADHESION; CELL LINE, TUMOR; DISEASE PROGRESSION; DNA METHYLATION; FLUORESCENT ANTIBODY TECHNIQUE; GLIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MATRIX ATTACHMENT REGION BINDING PROTEINS; MICE; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; UP-REGULATION;

EID: 84864252679     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-10-149     Document Type: Article

References (38)

1. Ruden E, Reardon DA, Coan AD, Herndon JE, Hornsby WE, West M, Fels DR, Desjardins A, Vredenburgh JJ, Waner E, Friedman AH, Friedman HS, Peters KB, Jones LW. Exercise behavior, functional capacity, and survival in adults with malignant recurrent glioma. J Clin Oncol 2011, 29:2918-23. 10.1200/JCO.2011.34.9852, 3138718, 21690470.
2. Chu SH, Ma YB, Feng DF, Zhang H, Zhu ZA, Li ZQ, Jiang PC. Correlation of low SLC22A18 expression with poor prognosis in patients with glioma. J Clin Neurosci 2012, 19:95-8. 10.1016/j.jocn.2011.04.032, 22153794.
3. Brandsma D, Stalpers L, Taal W, Sminia P, van den Bent MJ. Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas. Lancet Oncol 2008, 9:453-61. 10.1016/S1470-2045(08)70125-6, 18452856.
4. Kouzarides T. Histone acetylases and deacetylases in cell proliferation. Curr Opin Genet Dev 1999, 9:40-8. 10.1016/S0959-437X(99)80006-9, 10072350.
5. Dickinson LA, Joh T, Kohwi Y, Kohwi-Shigematsu T. A tissue-specific MARSAR DNA-binding protein with unusual binding site recognition. Cell 1992, 70:631-45. 10.1016/0092-8674(92)90432-C, 1505028.
6. Kumar PP, Purbey PK, Sinha CK, Notani D, Limaye A, Jayani RS, Galande S. Phosphorylation of SATB1, a global gene regulator, acts as a molecular switch regulating its transcriptional activity in vivo. Mol Cell 2006, 22:231-43. 10.1016/j.molcel.2006.03.010, 16630892.
7. Wen J, Huang S, Rogers H, Dickinson LA, Kohwi-Shigematsu T, Noguchi CT. SATB1 family protein expressed during early erythroid differentiation modifies globin gene expression. Blood 2005, 105:3330-9. 10.1182/blood-2004-08-2988, 15618465.
8. Cai S, Lee CC, Kohwi-Shigematsu T. SATB1 packages densely looped, transcriptionally active chromatin for coordinated expression of cytokine genes. Nat Genet 2006, 38:1278-88. 10.1038/ng1913, 17057718.
9. Patani N, Jiang W, Mansel R, Newbold R, Mokbel K. The mRNA expression of SATB1 and SATB2 in human breast cancer. Cancer Cell Int 2009, 9:18-27. 10.1186/1475-2867-9-18, 2731048, 19642980.
10. Agrelo R, Souabni A, Novatchkova M, Haslinger C, Leeb M, Komnenovic V, Kishimoto H, Gresh L, Kohwi-Shigematsu T, Kenner L, Wutz A. SATB1 defines the developmental context for gene silencing by Xist in lymphoma and embryonic cells. Dev Cell 2009, 16:507-16. 10.1016/j.devcel.2009.03.006, 19386260.
11. Cheng C, Lu X, Wang G, Zheng L, Shu X, Zhu S, Liu K, Wu K, Tong Q. Expression of SATB1 and heparanase in gastric cancer and its relationship to clinicopathologic features. APMIS 2010, 118:855-63. 10.1111/j.1600-0463.2010.02673.x, 20955458.
12. Wang S, Zhou J, Wang XY, Hao JM, Chen JZ, Zhang XM, Jin H, Liu L, Zhang YF, Liu J, Ding YQ, Li JM. Down-regulated expression of SATB2 is associated with metastasis and poor prognosis in colorectal cancer. J Pathol 2009, 219:114-22. 10.1002/path.2575, 19557828.
13. Zhao XD, Ji WY, Zhang W, He LX, Yang J, Liang HJ, Wang LL. Overexpression of SATB1 in laryngeal squamous cell carcinoma. ORL J Otorhinolaryngol Relat Spec 2010, 72:1-5. 10.1159/000264777, 20110741.
14. Yamayoshi A, Yasuhara M, Galande S, Kobori A, Murakami A. Decoy-DNA against special AT-rich sequence binding protein 1 inhibits the growth and invasive ability of human breast cancer. Oligonucleotides 2011, 21:115-21. 10.1089/oli.2010.0277, 21500976.
15. Han HJ, Russo J, Kohwi Y, Kohwi-Shigematsu T. SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis. Nature 2008, 452:187-93. 10.1038/nature06781, 18337816.
16. Ma C, Zhang J, Durrin LK, Lv J, Zhu D, Han X, Sun Y. The BCL2 major breakpoint region (mbr) regulates gene expression. Oncogene 2007, 26:2649-57. 10.1038/sj.onc.1210069, 17057736.
17. Chu SH, Feng DF, Ma YB, Zhang H, Zhu ZA, Li ZQ, Zhang ZH. Expression of HGF and VEGF in the cerebral tissue of adult rats with chronic hydrocephalus after subarachnoid hemorrhage. Mol Med Report 2011, 4:785-91.
18. Li SH, Tian H, Yue WM, Li L, Li WJ, Chen ZT, Hu WS, Zhu YC, Qi L. Overexpression of metastasis-associated protein 1 is significantly correlated with tumor angiogenesis and poor survival in patients with early-stage non-small cell lung cancer. Ann Surg Oncol 2011, 18:2048-56. 10.1245/s10434-010-1510-5, 21290196.
19. Generali D, Berruti A, Brizzi MP, Campo L, Bonardi S, Wigfield S, Bersiga A, Allevi G, Milani M, Aguggini S, Gandolfi V, Dogliotti L, Bottini A, Harris AL, Fox SB. Hypoxia-inducible factor-1alpha expression predicts a poor response to primary chemoendocrine therapy and disease-free survival in primary human breast cancer. Clin Cancer Res 2006, 12:4562-8. 10.1158/1078-0432.CCR-05-2690, 16899602.
20. Morrone FB, Oliveira DL, Gamermann P, Stella J, Wofchuk S, Wink MR, Meurer L, Edelweiss MI, Lenz G, Battastini AM. In vivo glioblastoma growth is reduced by apyrase activity in a rat glioma model. BMC Cancer 2006, 6:226. 10.1186/1471-2407-6-226, 1592110, 16995949.
21. Esteller M, Hamilton SR, Burger PC, Baylin SB, Herman JG. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res 1999, 59:793-797.
22. Chu SH, Ma YB, Feng DF, Zhang H, Qiu JH, Zhu ZA. Elevated expression of solute carrier family 22 member 18 increases the sensitivity of U251 glioma cells to BCNU. Oncol Lett 2011, 2:1139-42. 3406540, 22848278.
23. Li K, Cai R, Dai BB, Zhang XQ, Wang HJ, Ge SF, Xu WR, Lu J. SATB1 regulates SPARC expression in K562 cell line through binding to a specific sequence in the third intron. Biochem Biophys Res Commun 2007, 356:6-12. 10.1016/j.bbrc.2007.01.201, 17343824.
24. Xu Z, Shen G, Xia X, Zhao X, Zhang P, Wu H, Guo Q, Qian Z, Wei Y, Liang S. Comparisons of three polyethyleneimine-derived nanoparticles as a gene therapy delivery system for renal cell carcinoma. J Transl Med 2011, 9:46. 10.1186/1479-5876-9-46, 3108928, 21513541.
25. Liang D, Qin Y, Zhao W, Zhai X, Guo Z, Wang R, Tong L, Lin L, Chen H, Wong YC, Zhong Z. S-allylmercaptocysteine effectively inhibits the proliferation of colorectal cancer cells under in vitro and in vivo conditions. Cancer Lett. 2011, 310:69-76. 10.1016/j.canlet.2011.06.019, 21794975.
26. Chu SH, Feng DF, Ma YB, Zhang H, Zhu ZA, Li ZQ, Jiang PC. Promoter methylation and downregulation of SLC22A18 are associated with the development and progression of human glioma. J Transl Med 2011, 9:156. 10.1186/1479-5876-9-156, 3184631, 21936894.
27. Uemura K, Takao S, Aikou T. In vitro determination of basement membrane invasion predicts liver metastases in human gastrointestinal carcinoma. Cancer Res 1998, 58:3727-31.
28. Kanu OO, Mehta A, Di C, Lin N, Bortoff K, Bigner DD, Yan H, Adamson DC. Glioblastoma multiforme: a review of therapeutic targets. Expert Opin Ther Targets 2009, 13:701-18. 10.1517/14728220902942348, 19409033.
29. Squatrito M, Brennan CW, Helmy K, Huse JT, Petrini JH, Holland EC. Loss of ATM/Chk2/p53 pathway components accelerates tumor development and contributes to radiation resistance in gliomas. Cancer Cell 2010, 18:619-629. 10.1016/j.ccr.2010.10.034, 21156285.
30. Chu SH, Feng DF, Zhang H, Chen ET, Duan ZX, Li XY, Li J, Ma YB, Zhu ZA, Qiu JH. c-Met-targeted RNA interference inhibits growth and metastasis of glioma U251 cells in vitro. J Neurooncol 2009, 93:183-9. 10.1007/s11060-008-9772-5, 19165419.
31. Dong Y, Jia L, Wang X, Tan X, Xu J, Deng Z, Jiang T, Rainov NG, Li B, Ren H. Selective inhibition of PDGFR by imatinib elicits the sustained activation of ERK and downstream receptor signaling in malignant glioma cells. Int J Oncol 2011, 38:555-69.
32. Krangel MS. T cell development: better living through chromatin. Nat Immunol 2007, 8:687-694. 10.1038/ni1484, 17579647.
33. Purbey PK, Singh S, Notani D, Kumar PP, Limaye AS, Galande S. Acetylation-dependent interaction of SATB1 and CtBP1 mediates transcriptional repression by SATB1. Mol Cell Biol 2009, 29:1321-37. 10.1128/MCB.00822-08, 2643834, 19103759.
34. Yeh TY, Chuang JZ, Sung CH. Dynein light chain rp3 acts as a nuclear matrix-associated transcriptional modulator in a dynein-independent pathway. J Cell Sci 2005, 118:3431-43. 10.1242/jcs.02472, 16079286.
35. Seo J, Lozano MM, Dudley JP. Nuclear matrix binding regulates SATB1-mediated transcriptional repression. J Biol Chem 2005, 280:24600-9. 10.1074/jbc.M414076200, 15851481.
36. Pavan KP, Purbey PK, Sinha CK. Phosphorylation of SATB1, a global gene regulator, acts as a molecular switch regulating its transcriptional activity in vivo. Mol Cell 2006, 22:231-43. 10.1016/j.molcel.2006.03.010, 16630892.
37. Kreth S, Thon N, Eigenbrod S, Lutz J, Ledderose C, Egensperger R, Tonn JC, Kretzschmar HA, Hinske LC, Kreth FW. O6-methylguanine-DNA methyltransferase (MGMT) mRNA expression predicts outcome in malignant glioma independent of MGMT promoter methylation. PLoS One 2011, 6:e17156. 10.1371/journal.pone.0017156, 3041820, 21365007.
38. Liu BL, Cheng JX, Zhang W, Zhang X, Wang R, Lin H, Huo JL, Cheng H. Quantitative detection of multiple gene promoter hypermethylation in tumor tissue, serum, and cerebrospinal fluid predicts prognosis of malignant gliomas. Neuro Oncol 2010, 12:540-8. 10.1093/neuonc/nop064, 2940650, 20154338.